Cocrystal Pharma

COCP48

Penny Stock

$1.84arrow_drop_up4.54%$0.08

Penny Stock

COCP48

$1.84

arrow_drop_up4.54%$0.08

Penny Stock

Performance History

Key Stats
Open	$1.72
Prev. Close	$1.76
EPS	-1.75
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$17.80M
PE Ratio	-

	LOW	HIGH
Day Range	1.72	1.77
52 Week Range	1.33	3.10

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.75

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Cocrystal Pharma (COCP)

Cocrystal Pharma Inc (COCP) is a biotechnology company focused on discovering and developing novel antiviral therapeutics. The company's primary goal is to create effective treatments for viral diseases that are currently lacking effective options. With a strong emphasis on the use of structure-based drug design, Cocrystal Pharma aims to target viral replication and to inhibit the virus from spreading within the host. By developing proprietary antiviral compounds, the company hopes to make a significant impact on global public health.

Cocrystal Pharma Inc's stock price history has shown some fluctuations over the years. It is advisable to consult reliable financial sources for the most up-to-date information on the stock's performance. The company's stock quote provides real-time data on the current market price of COCP. Additionally, investors can access the latest stock news to stay informed about any significant developments within the company or the industry as a whole. The stock analysis of Cocrystal Pharma Inc can help investors assess the company's financial health and make informed investment decisions based on market trends and expert opinions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Sam Lee Ph.D.
Headquarters: Bothell
Employees: 12
Exchange: NASDAQ

Keep an eye on Cocrystal Pharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Cocrystal Pharma 's (COCP) price per share?

The current price per share for Cocrystal Pharma (COCP) is $1.84. The stock has seen a price change of $0.08 recently, indicating a 4.55% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Cocrystal Pharma (COCP)?

For Cocrystal Pharma (COCP), the 52-week high is $3.1, which is 68.48% from the current price. The 52-week low is $1.33, the current price is 38.35% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Cocrystal Pharma (COCP) a growth stock?

Cocrystal Pharma (COCP) has shown an average price growth of 0.41% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cocrystal Pharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Cocrystal Pharma (COCP) stock price performance year to date (YTD)?

As of the latest data, Cocrystal Pharma (COCP) has a year-to-date price change of 4.68%. Over the past month, the stock has experienced a price change of -3.66%. Over the last three months, the change has been -30.83%. Over the past six months, the figure is 21.85%. Looking at a longer horizon, the five-year price change stands at -92.33%.

help

Is Cocrystal Pharma (COCP) a profitable company?

Cocrystal Pharma (COCP) has a net income of -$17.98M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $1.39M. Operating income is noted at -$21.16M. Furthermore, the EBITDA is -$21.15M.

help

What is the market capitalization of Cocrystal Pharma (COCP)?

Cocrystal Pharma (COCP) has a market capitalization of $18.72M. The average daily trading volume is 13.18K, indicating the stock's liquidity and investor engagement.